FDA
-
-
-
-
-
-
-
Perspective Therapeutics Announces the Awarding of a $1 million Collaborative Grant to King’s College London to Support Radiobiology Research of Alpha Particle Therapy for Cancer
-
-
-
-
-
-
-
Study Finds Excellent Outcomes for Intermediate Risk Prostate Cancer Patients Treated with Isoray’s Cesium-131
-
-
-
-
-
-
-
Isoray Announces Pricing of $45 Million Public Offering
-
-
-
-
-
-
-
IsoRay (ISR) Prices 9.135M Share & Warrants Offering at $0.52/Sh
-
-
-
-
-
-
-
Isoray Announces Second Quarter Fiscal 2020 Financial Results
-
-
-
-
-
-
-
A Decade of Data Shows the Value of Isoray’s Cesium-131 As Prostate Cancer Internal Radiation Therapy Treatment
-
-
-
-
-
-
-
IsoRay (ISR) Announces Appointment of Lori Woods as CEO
-
322,236 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

